Tuesday, May 14, 2024

VA to award contract for mobile Menopause Symptom Tracking Tool continued engineering services

Notice ID: 36C26122Q0470

“Under Statutory Authority U.S.C. 253(c)(1) the Government anticipates entering into a sole source procurement negotiation with NITID BIT LLC to provide continued engineering services for a mobile application tracking tool for menopausal related research for the Department of Veterans Affairs (VA), San Francisco…”

“Description: Nitid Bit LLC (“Nitid”) previously provided software design and engineering services to the U.S. Department of Veterans Affairs (“VA”) toward the development of a support tool for Veterans during the menopause transition. Additional software and engineering services toward the development of additional features and refinement of existing prototype features guided by

Veteran user feedback are needed. This tool is a native mobile application and will provide the basis for clinical studies led by Principal Investigator Carolyn Gibson, PhD, MPH.”

“Scope of Work: Vendor will provide 172 hours of software engineering time toward the feature list outlined below. Work will be completed as prioritized by the VA principal investigator, Carolyn Gibson, and will be managed via a Pivotal Tracker project. Features will be completed as time and budget allow. The tool will fulfill the requirements and provide the features in the list below.

  • Create a weekly summary page (up to 1 per symptom)
  • Edit and refine features and design elements based on user feedback
  • Interrogate and fix program bugs
  • If approved, put the app into the Apple App Store and Android Store
  • Features are accessible (meet 508 guidelines)
  • Record symptom data to a server for analysis by primary investigator…”

Read more here.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

FedHealthIT Xtra – Find Out More!

Recent News

Don’t Miss A Thing

Jackie Gilbert
Jackie Gilbert
Jackie Gilbert is a Content Analyst for FedHealthIT and Author of 'Anything but COVID-19' on the Daily Take Newsletter for G2Xchange Health and FedCiv.

Subscribe to our mailing list

* indicates required